Evidence map›Paper›PMID 15579025›Full record

ReviewCurrent molecular medicine2004

Cross-talk between nitric oxide and transforming growth factor-beta1 in malaria.

Yoram Vodovotz, Ruben Zamora, Matthew J Lieber, Shirley Luckhart

Open access · greenAbstract readReview
In one paragraph

Review in Current molecular medicine, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.3field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Frontiers in cellular and infection microbiology · 2019
    Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Yoram VodovotzDepartment of Surgery, University of Pittsburgh, Pittsburgh, PA 15213, USA. vodovotzy@msx.upmc.edu
Ruben Zamora
Matthew J Lieber
Shirley Luckhart
University of Pittsburgh · US

Funding

Cross-talk among mosquito and mammalian immune factorsR01AI050663 · NIAID · VIRGINIA POLYTECHNIC INST AND ST UNIV · PI LUCKHART, SHIRLEY · 2004 to 2008
$1.6M
NIAID NIH HHS R01 AI050663
6 · The paper itself

Abstract

Malaria has re-emerged as a global health problem, leading to an increased focus on the cellular and molecular biology of the mosquito Anopheles and the parasite Plasmodium with the goal of identifying novel points of intervention in the parasite life cycle. Anti-parasite defenses mounted by both mammalian hosts and Anopheles can suppress the growth of Plasmodium. Nonetheless, the parasite is able to escape complete elimination in vivo, perhaps by thwarting or co-opting these mechanisms for its own survival, as do numerous other pathogens. Among the defense systems used by the mammalian host against Plasmodium is the synthesis of nitric oxide (NO), catalyzed by an inducible NO synthase (iNOS). Nitric oxide produced by the action of an inducible Anopheles stephensi NO synthase (AsNOS) may be central to the anti-parasitic arsenal of this mosquito. In mammals, iNOS can be modulated by members of the transforming growth factor-beta (TGF-beta) cytokine superfamily. Transforming growth factor-beta is produced as an inactive precursor that is activated following dissociation of certain inhibitory proteins, a process that can be promoted by reaction products of NO as well as by hemin. Ingestion by Anopheles of blood containing Plasmodium initiates parasite development, blood digestion which results in the accumulation of hematin (hemin) in the insect midgut, and induction of both AsNOS and TGF-beta-like (As60A) gene expression in the midgut epithelium. Active mammalian TGF-beta1 can be detected in the A. stephensi midgut up to 48h post-ingestion and latent TGF-beta1 can be activated by midgut components in vitro, a process that is potentiated by NO and that may involve hematin. Further, mammalian TGF-beta1 is perceived as a cytokine by A. stephensi cells in vitro and can alter Plasmodium development in vivo. Bloodfeeding by Anopheles, therefore, results in a juxtaposition of evolutionarily conserved mosquito and mammalian TGF-beta superfamily homologs that may influence transmission dynamics of Plasmodium in endemic regions.

Indexed as

AnimalsAnophelesCytokinesHemeHumansInsect ProteinsMalariaNitric OxideNitric Oxide SynthaseNitric Oxide Synthase Type IINitrogen OxidesPlasmodiumSignal TransductionTransforming Growth Factor betaTransforming Growth Factor beta1CytokinesHemeInsect ProteinsNitric OxideNitric Oxide SynthaseNitric Oxide Synthase Type IINitrogen OxidesnitroxylNOS2 protein, humanTGFB1 protein, humanTransforming Growth Factor betaTransforming Growth Factor beta1

Identifiers

PMID15579025
PMCPMC2590626
OpenAlexW2162846345

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.